Operator: Good afternoon, ladies and gentlemen and thank you for standing by. Welcome to the Pulse Biosciences First Quarter 2023 Earnings Conference Call.
Pulse Biosciences, Inc. , a company leveraging its novel and proprietary nanosecond pulsed field ablation technology for the treatment of atrial fibrillation, today announced financial results for. | May 11, 2023
Pulse Biosciences Reports Business Updates and First Quarter 2023 Financial Results streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.